gold has been researched along with Drug Withdrawal Symptoms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aalinkeel, R; Gleason, CP; Ignatowski, TA; Law, WC; Mahajan, SD; Mammen, MJ; Nair, BB; Prasad, PN; Reynolds, JL; Schwartz, SA; Sykes, DE | 1 |
| Pandey, SC; Zhang, H | 1 |
| Anastassiades, TP; Dwosh, IL; Ford, PM; Kean, WF; Kelly, HG | 1 |
3 other study(ies) available for gold and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Nanotherapeutic approach for opiate addiction using DARPP-32 gene silencing in an animal model of opiate addiction.
Topics: Animals; Avoidance Learning; Cell Line; Cyclic AMP Response Element-Binding Protein; Dopamine and cAMP-Regulated Phosphoprotein 32; Down-Regulation; Gene Silencing; Genetic Therapy; Gold; Humans; Morphine Dependence; Nanomedicine; Nanotubes; Opioid-Related Disorders; Protein Phosphatase 1; Rats; Rats, Long-Evans; RNA, Small Interfering; Substance Withdrawal Syndrome | 2015 |
Effects of PKA modulation on the expression of neuropeptide Y in rat amygdaloid structures during ethanol withdrawal.
Topics: Alcohol Drinking; Amygdala; Animals; Cyclic AMP-Dependent Protein Kinases; Ethanol; Gene Expression Regulation; Gold; Male; Neuropeptide Y; Rats; Rats, Sprague-Dawley; RNA, Messenger; Staining and Labeling; Substance Withdrawal Syndrome | 2003 |
The toxicity pattern of D-penicillamine therapy. A guide to its use in rheumatoid arthritis.
Topics: Adolescent; Adult; Aged; Arthritis, Rheumatoid; Blood Sedimentation; Child; Digestive System; Dose-Response Relationship, Drug; Female; Gold; Humans; Male; Middle Aged; Neutropenia; Penicillamine; Proteinuria; Remission, Spontaneous; Substance Withdrawal Syndrome; Taste Disorders; Thrombocytopenia; Time Factors | 1980 |